Banner Image

prescription-drug-news-regulations-employers

Prescription Drug News of Note - November 2018

Nov 30, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: Generic for MS | New recommendations on HIV therapy | FDA approves new cancer medication with a unique indication
Read more ▸▸

Prescription Drug News of Note - October 2018

Oct 30, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: Cholesterol drug price reduction?! New FDA approval on a flu treatment | Comparative results of two MS products | FDA expands indication for Hemophilia medication
Read more ▸▸

Prescription Drug News of Note - September 2018

Oct 1, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: This month includes figures on the prevalence of Diabetes among US adults, new Migraine management products, Vascepa showing reduction in cardiovascular events, and new Hepatitis C generics,.
Read more ▸▸

Prescription Drug News of Note - August 2018

Aug 29, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: This month includes news on FDA approval of a first-of-its-kind peripheral nerve disease (polyneuropathy) therapy, and the latest on Teva's EpiPen generic
Read more ▸▸

Prescription Drug News of Note - July 2018

Jul 31, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: This month includes news on FDA approval of Tibsovo and Nivestym, and highlights positive results from an Alzheimer's trial
Read more ▸▸

Prescription Drug News of Note - June 2018

Jun 29, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: This month includes news on FDA approval of marijuana-based seizure medication, thoughts on whether OLUMIANT change inflammatory drug pricing, an analysis of Part D spending on brand drugs, and last but not least, Amazon's acquisition of PillPack.
Read more ▸▸

Prescription Drug News of Note - May 2018

May 31, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: Positive clinical results for Praulent, more M&A activity with Cigna and Express Scripts, and the recent JAMA study on US Healthcare Spending
Read more ▸▸

Prescription Drug News of Note - April 2018

Apr 27, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: Positive clinical results for Praulent, more M&A activity with Cigna and Express Scripts, and the recent JAMA study on US Healthcare Spending
Read more ▸▸

Making Sense of Benefit M&A

Mar 29, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Pharmacy Benefit Managers
With recent mergers like the Cigna/Express Scripts (ESI) deal, stakeholders across the pharmaceutical industry are curious about the future of independent PBMs, the future of pharmacy carve-out, the opportunity for Truveris, and if/how Amazon can be a catalyst to a major change in the way that we experience, and pay for, healthcare.
Read more ▸▸

Prescription Drug News of Note - March 2018

Mar 27, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: Positive clinical results for Praulent, more M&A activity with Cigna and Express Scripts, and the recent JAMA study on US Healthcare Spending
Read more ▸▸

Prescription Drug News of Note - February 2018

Feb 27, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: FDA Approvals, Prescription spending trends, and the latest on Albertson's and Rite Aid
Read more ▸▸

Prescription Drug News of Note - January 2018

Jan 26, 2018 | Trends, Insights & Analysis, Prescription Drug News & Regulations - Employers, Enterprise Employers
Each month, we round up the latest FDA approvals and regulations: FDA Approves 46 Novel Medications in 2017, Hospitals to Start Their Own Generic Drug Company
Read more ▸▸

Prescription Drug News of Note - November 2017

Nov 28, 2017 | Trends, Insights & Analysis, Brokers, Enterprise Employers, Labor Unions, State & Public Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations... FDA approves Lyrica CR capsules, Imprimis Pharmaceuticals announces alternative to Restasis
Read more ▸▸

Prescription Drug News of Note - October 2017

Oct 15, 2017 | Trends, Insights & Analysis, Brokers, Enterprise Employers, Labor Unions, State & Public Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations to give you an expert take on what you need to know.
Read more ▸▸

Prescription Drug News of Note - September 2017

Sep 11, 2017 | Trends, Insights & Analysis, Brokers, Enterprise Employers, Labor Unions, State & Public Employers, Prescription Drug News & Regulations - Employers
Each month, we round up the latest FDA approvals and regulations to give you an expert take on what you need to know.
Read more ▸▸

Prescription Drug News of Note – August 2017

Aug 1, 2017 | Trends, Insights & Analysis, Enterprise Employers, Brokers, Labor Unions, State & Public Employers, Prescription Drug News & Regulations - Employers
A rundown of the latest FDA approvals and regulations from August 2017, with an expert take on what you need to know in the prescription drug industry.
Read more ▸▸

10 Questions Employers Should Be Asking About the Cadillac Tax

Apr 20, 2016 | Trends, Insights & Analysis, Enterprise Employers, Prescription Drug News & Regulations - Employers
The Cadillac Tax is an excise tax levied on employers that provide high-cost health benefit plans to their employees.
Read more ▸▸